Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Savage97on Nov 08, 2020 7:59am
315 Views
Post# 31859096

King Cannabis Irwin Simon CEO of the Year!

King Cannabis Irwin Simon CEO of the Year!

Well, Aphria now has will have more US and Beverage revenue than Canopy.  if You consider their 420 brand “cannabis related” (Terpenes and such but that’s a stretch) I could argue Aphria will have more Cannabis (read hemp) drink revenue than Canopy. It cost shareholders much less than CGC’s attempts to enter the US thus far considering they’re using a credit line for part of the purchase and dilution is minimal since Aquisition is financially accretive And APHA can actually realize the monies from US sales on their balance sheet. Plus with Covid impacting sales it’s possible SweetWater was had for a small discount relative to if Covid had not been a thing.

Canopy on the other hand spent +$300M on an obligatory “option”, no immediate (or guaranteed future) returns for that “investment” and the company (ACRG) is not exactly a top Teer performer.

Lord Jones was $300m for how much revenue and assets? Is that an overcrowded market or a growing one?

SweetWater has current distribution ability and infrastructure in over half the USA (including Costco and airlines), and products in multiple countries across the Atlantic. Growing market with cannabis focused branding and popular products. It’s easy to expand an already functioning beverage facility to include cannabis extraction and infusion especially in a cannabis progressive state. Or leverage the physical assets to work with Cannabis distributionwithin USA once permissible.

In the meanwhile the $29Billion annual craft brewing market continues to grow in favour of flavourless options.

Immediate accretion to balance sheet, minimal dilution in the true sense of the word, immediate realizable revenue in a growing US market, and established brands that already resonate with cannabis culture.

It really is just math and attempting to generate immediate positive income instead of hype for future potential from operations.

copied from TheCannalysts 

'In the U.S., Aphria is taking advantage in (the craft brewing) industry, but at the same time leveraging it for cannabis.  The deal was about cash-flow generation that provides us an avenue to continue to build a war chest for further entries into the U.S. as we continue to build out the U.S. opportunity".

<< Previous
Bullboard Posts
Next >>